Author:
Oseran Andrew S.,Wadhera Rishi K.
Funder
National Heart Lung and Blood Institute Division of Intramural Research
American Heart Association Inc
Patrick and Catherine Weldon Donaghue Medical Research Foundation
National Heart, Lung, and Blood Institute
Reference7 articles.
1. Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States;Wang;J Am Heart Assoc,2021
2. The Inflation Reduction Act and out-of-pocket drug costs for Medicare beneficiaries with cardiovascular disease;Kazi;J Am Coll Cardiol,2023
3. H.R.5376: 117th Congress (2021–2022): Inflation Reduction Act of 2022. Accessed August 16, 2022. http://www.congress.gov/.
4. Narasimmaraj PR, Oseran A, Tale A, Xu J, Essien UR, Kazi DS, et al. Out-of-pocket drug costs for Medicare beneficiaries with cardiovascular risk factors/conditions under the Inflation Reduction Act. J Am Coll Cardiol 2023;81:1491–1501. http://doi.org/10.1016/j.jacc.2023.02.002.
5. The Inflation Reduction Act and access to high-cost cardiovascular therapies;Kazi;JAMA,2023